Determination of optimal neuromuscular reversal dose of Sugammadex in pediatric patients
Not Applicable
- Conditions
- Surgical pediatric patients undergoing general anesthesia
- Registration Number
- JPRN-UMIN000007276
- Lead Sponsor
- Asahikawa Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 32
Inclusion Criteria
Not provided
Exclusion Criteria
1.patients with liver and renal dysfunction 2.patients with neuromuscular disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method It is possible to determine the necessity of additional Sugammadex for the complete reversal of neuromuscular block in a short post-operative period.
- Secondary Outcome Measures
Name Time Method